Poster (Scientific congresses and symposiums)
Thiamine and benfotiamine improve memory, decrease depressive-like behavior and reduce brain expression of GSK3 beta in mice
Markova, N; Shevtsova, E; Vignisse, Julie et al.
20148th International Conference on Thiamine: From Catalysis to Pathology
 

Files


Full Text
Markova-Abstract.pdf
Author postprint (332.64 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Thiamine; Benfotiamine; memory
Abstract :
[en] An increasing body of evidence suggests an implication of altered thiamine metabolism in mental illnesses, including depression and Alzheimer’s disease. Here, we examined the effects of a two-week treatment with thiamine (200 mg/kg/day) or benfotiamine (200 mg/kg/day, a synthetic thiamine precursor of high bioavailability, on learning of C57 mice in step down avoidance (SDA) and fear conditioning (FC) tests and depressive-like behavior in the modified forced swimming test (modFST). In addition, we investigated the effects of these drugs on brain gene expression of Glycogene Synthase Kinase 3beta (GSK3b), a regulatory factor that is involved in both above-mentioned mental conditions. Benfotiamine, but not thiamine significantly increased contextual learning in C57 mice in the step-down paradigm and acquisition of fear conditioning during weak training. Both compounds have improved the extinction of contextual fear conditioning memory and did not alter the acquisition of fear conditioning during strong training. Also, we found that both treatments reduced depressive-like behavior in mice, as shown by diminished duration of floating behavior in the modified forced swim test. With the modified forced swimming test applied here, an additional swimming session was carried out 120 hours after the first trial and resulted in increased mRNA levels of GSK3b in the prefrontal cortex, which correlated with duration of floating in tested mice. Thiamine and benfotiamine reduced GSK3b expression in the prefrontal cortex and the hippocampus that was more pronounced in the animals with low floating, in case of the measurements made in the prefrontal cortex. Together, these data suggest pro-cognitive and antidepressant-like effect of benfotiamine that are partly shared by thiamine and can be mediated by their inhibitory effect on the GSK3b
Research center :
Giga-Neurosciences - ULiège
Disciplines :
Biochemistry, biophysics & molecular biology
Author, co-author :
Markova, N
Shevtsova, E
Vignisse, Julie ;  Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Biochimie et physiologie humaine et pathologique
Zubareva, O
Trofimov, Alexey
Steinbusch, Harry
Bachurin, Sergey
Bettendorff, Lucien  ;  Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Biochimie et physiologie humaine et pathologique
Strekalova, Tatyana
Language :
English
Title :
Thiamine and benfotiamine improve memory, decrease depressive-like behavior and reduce brain expression of GSK3 beta in mice
Publication date :
May 2014
Event name :
8th International Conference on Thiamine: From Catalysis to Pathology
Event organizer :
Lucien Bettendorff, Université de Liège, GIGA-Neurosciences
Event place :
Liège, Belgium
Event date :
May 23 – 26 2014
Audience :
International
Funders :
FRIA - Fonds pour la Formation à la Recherche dans l'Industrie et dans l'Agriculture [BE]
SAO-FRA
Available on ORBi :
since 20 November 2014

Statistics


Number of views
1295 (10 by ULiège)
Number of downloads
12 (5 by ULiège)

Bibliography


Similar publications



Contact ORBi